Moreover, proinflammatory cytokines synthesized during COVID-19 or in response to vaccines may promote the expression of VEGF-A [42,135], whereas inflammation and hypoxia may decrease the expression of VEGF-R2, NRP-1, and NRP-2, as observed in preclinical studies [159,160]. The gene discussed is NRP1; the disease is COVID-19.